Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy

Documenti analoghi

• Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy
  di: Sam Gandy, et al.
  Pubblicazione: (2023-11-01)
• Oxidative stress: culprit or consequence in Alzheimer’s amyloidopathy
  di: Chanchal Sharma, et al.
  Pubblicazione: (2023-01-01)
• INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model
  di: Akihiro Iguchi, et al.
  Pubblicazione: (2023-04-01)
• The Role of Vitamin D in Alzheimer’s Disease: A Transcriptional Regulator of Amyloidopathy and Gliopathy
  di: Jiseung Kang, et al.
  Pubblicazione: (2022-07-01)
• Dual role of miR-155 and exosomal miR-155 in tumor angiogenesis: implications for cancer progression and therapy
  di: Qusay Mohammed Hussain, et al.
  Pubblicazione: (2025-05-01)